[1]
2023. Cases of Meige’s Syndrome Controlled Following Administration of Low-Dose Botulinum Toxin Type-A: A Serial Case Series. Magna Neurologica. 1, 2 (Jul. 2023), 41–43. DOI:https://doi.org/10.20961/magnaneurologica.v1i2.700.